Product Description
Disease-Modifying Antirheumatic Agent
Tocilizumab, Preservative Free
162 mg / 0.9 mL Subcutaneous Injection
Prefilled Syringe , 0.9 mL
Genentech 50242013801″ title=”Actemra
Disease-Modifying Antirheumatic Agent
Tocilizumab, Preservative Free
162 mg / 0.9 mL Subcutaneous Injection
Prefilled Syringe , 0.9 mL
Genentech 50242013801″ />Actemra
Disease-Modifying Antirheumatic Agent
Tocilizumab, Preservative Free 162 mg / 0.9 mL
Subcutaneous Injection
Prefilled Syringe , 0.9 mL
Genentech 50242013801
1- REGULATIONS ON PURCHASE OF THESE PRODUCTS VARY FROM STATE TO STATE . IT IS THE PURCHASER’S RESPONSIBILITY TO KNOW AND COMPLY WITH THE LAWS GOVERNING THE DISTRICT IN WHICH THEY LIVE.2-THESE ITEMS WOULD BE USED ONLY BY QUALIFIED CUSTOMERS ( PHYSICIAN OFFICES , DIAGNOSTIC & RESEARCH LABORATORIES , HEALTH CARE PROVIDERS , …. ) WITH VALID PROFESSIONAL LICENSE.3- ANY INQUIRY REGARDING THESE ITEMS WOULD BE PROCESSED AFTER VERIFICATION OF VALID LICENSE TO BE EMAILED AS AN ATTACHMENT TO : [email protected] OR FAXED TO 323-782-0985 )
Manufacturer 50242013801Brand Actemra®Manufacturer Genentech USAApplication Disease-Modifying Antirheumatic AgentContainer Type Prefilled SyringeDosage Form InjectionGeneric Drug Code 35486Generic Drug Name Tocilizumab, Preservative FreeNDC Number 50242-0138-01Strength 162 mg / 0.9 mLType SubcutaneousVolume 0.9 mLFeatures
ACTEMRA (tocilizumab) is a recombinant humanized anti-human interleukin 6 (IL-6) receptor monoclonal antibody of the immunoglobulin IgG1? (gamma 1, kappa) subclass with a typical H2L2 polypeptide structure ACTEMRA solution for subcutaneous administration is supplied as a sterile, colorless to yellowish, preservative-free liquid solution of approximately pH 6.0 It is supplied in a 1 mL ready-to-use, single-use prefilled syringe (PFS) with a needle safety device Each device delivers 0.9 mL (162 mg) of ACTEMRA, in a histidine buffered solution composed of ACTEMRA (180 mg/mL), polysorbate 80, L-histidine and L-histidine monohydrochloride, L-arginine and L-arginine hydrochloride, L-methionine, and water for injection
